Abstract
The main diagnostic tools used to look for evidence of prostate cancer include digital rectal examination (DRE), serum concentration of prostate-specific antigen (PSA), and transrectal ultrasonography (TRUS)-guided biopsy [2]. In this chapter, we review the clinical role for TRUS and recent ultrasonography developments in the detection and diagnosis of prostate disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.
Scardino PT, Weaver R, Hudson MA. Early detection of prostate cancer. Hum Pathol. 1992;23(3):211–22.
Takahashi H, Ouchi T. The ultrasonic diagnosis in the field of urology. Proc Jpn Soc Ultrasonics Med. 1963;3:7.
Langer JE. The current role of transrectal ultrasonography in the evaluation of prostate carcinoma. Semin Roentgenol. 1999;34(4):284–94.
Watanabe H, Igari D, Tanahasi Y, Harada K, Saito M. Development and application of new equipment for transrectal ultrasonography. J Clin Ultrasound. 1974;2(2):91–8.
Rifkin MD. Ultrasound of the prostate–applications and indications. Schweiz Med Wochenschr. 1991;121(9):282–91.
Beerlage HP. Alternative therapies for localized prostate cancer. Curr Urol Rep. 2003;4(3):216–20.
Frauscher F, Gradl J, Pallwein L. Prostate ultrasound – for urologists only? Cancer Imaging. 2005;5(Spec No A):S76–82.
Kranse R, Beemsterboer P, Rietbergen J, Habbema D, Hugosson J, Schroder FH. Predictors for biopsy outcome in the European randomized study of screening for prostate cancer (Rotterdam region). Prostate. 1999;39(4):316–22.
Littrup PJ, Bailey SE. Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management. Radiol Clin North Am. 2000;38(1):87–113.
Lee F, Torp-Pedersen ST, Siders DB, Littrup PJ, McLeary RD. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology. 1989;170(3 Pt 1):609–15.
Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142(1):71–4; discussion 74–5.
Presti Jr JC, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 2000;163(1):163–6; discussion 166–7.
Gore JL, Shariat SF, Miles BJ, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001;165(5):1554–9.
Stroumbakis N, Cookson MS, Reuter VE, Fair WR. Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology. 1997;49(3A Suppl):113–8.
Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Galluzzi C, Jones JS. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy. J Urol. 2008;179(5):1746–50; discussion 1750.
Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol. 2006;175(5):1605–12.
Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localized disease. Eur Urol. 2010;59(1):61–74. Accessed on Jan 2011.
Carroll P, Albertsen PC, Green K, et al. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Williston Park). 2009;14(2):267–272, 277–268, 280 passim.
Gosselaar C, Roobol MJ, Roemeling S, Wolters T, van Leenders GJ, Schroder FH. The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer. BJU Int. 2008;101(6):685–90.
Heijmink SW, van Moerkerk H, Kiemeney LA, Witjes JA, Frauscher F, Barentsz JO. A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. Eur Radiol. 2006;16(4):927–38.
Durkan GC, Greene DR. Diagnostic dilemmas in detection of prostate cancer in patients undergoing transrectal ultrasound-guided needle biopsy of the prostate. Prostate Cancer Prostatic Dis. 2000;3(1):13–20.
Huang Foen Chung JW, de Vries SH, Raaijmakers R, Postma R, Bosch JL, van Mastrigt R. Prostate volume ultrasonography: the influence of transabdominal versus transrectal approach, device type and operator. Eur Urol. 2004;46(3):352–6.
Stravodimos KG, Petrolekas A, Kapetanakis T, et al. TRUS versus transabdominal ultrasound as a predictor of enucleated adenoma weight in patients with BPH: a tool for standard preoperative work-up? Int Urol Nephrol. 2009;41(4):767–71.
Ozden E, Gogus C, Kilic O, Yaman O, Ozdiler E. Analysis of suprapubic and transrectal measurements in assessment of prostate dimensions and volume: is transrectal ultrasonography really necessary for prostate measurements? Urol J. 2009;6(3):208–13.
Blanc M, Sacrini A, Avogadro A, et al. Prostatic volume: suprapubic versus transrectal ultrasonography in the control of benign prostatic hyperplasia. Radiol Med. 1998;95(3):182–7.
Ching CB, Moussa AS, Li J, Lane BR, Zippe C, Jones JS. Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates. J Urol. 2009;181(5):2077–82; discussion 2082–73.
Karlsson G. The physics of ultrasound and some recent techniques used. In: Ukimura O, Gill IS, editors. Contemporary interventional ultrasonography in urology. London: Springer; 2009. p. 103–12.
Kossoff G. Basic physics and imaging characteristics of ultrasound. World J Surg. 2000;24(2):134–42.
Kremkau F. Ultrasound physics. Ultrasound Med Biol. 1991;17(4):411.
Coltrera MD. Ultrasound physics in a nutshell. Otolaryngol Clin North Am. 2010;43(6):1149–59, v.
Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol. 1991;145(5):984–7.
Loch AC, Bannowsky A, Baeurle L, et al. Technical and anatomical essentials for transrectal ultrasound of the prostate. World J Urol. 2007;25(4):361–6.
Bates TS, Reynard JM, Peters TJ, Gingell JC. Determination of prostatic volume with transrectal ultrasound: a study of intra-observer and interobserver variation. J Urol. 1996;155(4):1299–300.
Kamoi K, Babaian RJ. Contemporary TRUS-guided prostate biopsy for screening and staging. In: Ukimura O, Gill IS, editors. Contemporary interventional ultrasonography in urology. London: Springer; 2009. p. 49–62.
Bangma CH, Hengeveld EJ, Niemer AQ, Schroder FH. Errors in transrectal ultrasonic planimetry of the prostate: computer simulation of volumetric errors applied to a screening population. Ultrasound Med Biol. 1995;21(1):11–6.
Cunha GR, Ricke W, Thomson A, et al. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol. 2004;92(4):221–36.
Mong A, Bellah R. Imaging the pediatric prostate. Radiol Clin North Am. 2006;44(5):749–56, ix.
Walz J, Burnett AL, Costello AJ, et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol. 2010;57(2):179–92.
McNeal JE. The zonal anatomy of the prostate. Prostate. 1981;2(1):35–49.
Wasserman NF. Benign prostatic hyperplasia: a review and ultrasound classification. Radiol Clin North Am. 2006;44(5):689–710, viii.
Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer. 2000;89(8):1800–9.
Villers A, Steg A, Boccon-Gibod L. Anatomy of the prostate: review of the different models. Eur Urol. 1991;20(4):261–8.
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–9.
Hasegawa Y, Sakamoto N, Gotoh K. Relationship of ultrasonic and histologic findings in benign prostatic hyperplasia. Prostate. 1996;28(2):111–6.
Sohlberg OE, Chetner M, Ploch N, Brawer MK. Prostatic abscess after transrectal ultrasound guided biopsy. J Urol. 1991;146(2):420–2.
Ishikawa M, Okabe H, Oya T, et al. Midline prostatic cysts in healthy men: incidence and transabdominal sonographic findings. AJR Am J Roentgenol. 2003;181(6):1669–72.
Hamper UM, Epstein JI, Sheth S, Walsh PC, Sanders RC. Cystic lesions of the prostate gland. A sonographic – pathologic correlation. J Ultrasound Med. 1990;9(7):395–402.
Galosi AB, Montironi R, Fabiani A, Lacetera V, Galle G, Muzzonigro G. Cystic lesions of the prostate gland: an ultrasound classification with pathological correlation. J Urol. 2009;181(2):647–57.
Sauvain JL, Palascak P, Bourscheid D, et al. Value of power Doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. Eur Urol. 2003;44(1):21–30; discussion 30–21.
Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997;50(4):562–6.
Hammerer P, Huland H. Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol. 1994;151(1):99–102.
Ellis WJ, Chetner MP, Preston SD, Brawer MK. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol. 1994;152(5 Pt 1):1520–5.
Ukimura O, Troncoso P, Ramirez EI, Babaian RJ. Prostate cancer staging: correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension. J Urol. 1998;159(4):1251–9.
Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology. 2007;243(1):28–53.
Ohori M, Shinohara K, Wheeler TM, et al. Ultrasonic detection of non-palpable seminal vesicle invasion: a clinicopathological study. Br J Urol. 1993;72(5 Pt 2):799–808.
Neumaier CE, Martinoli C, Derchi LE, Silvestri E, Rosenberg I. Normal prostate gland: examination with color Doppler US. Radiology. 1995;196(2):453–7.
Wilson NM, Masoud AM, Barsoum HB, Refaat MM, Moustafa MI, Kamal TA. Correlation of power Doppler with microvessel density in assessing prostate needle biopsy. Clin Radiol. 2004;59(10):946–50.
Mitterberger M, Pallwein L, Frauscher F. Prostate carcinoma: conventional imaging techniques – gray-scale, color, and power Doppler ultrasound. In: De La Rosette JJ, editor. Imaging in oncological urology. London: Springer; 2009. p. 221–8.
Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology. 1993;186(2):509–13.
Remzi M, Dobrovits M, Reissigl A, et al. Can power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol. 2004;46(4):451–6.
Lavoipierre AM, Snow RM, Frydenberg M, et al. Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol. 1998;171(1):205–10.
Cho JY, Kim SH, Lee SE. Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound. Eur Urol. 2000;37(4):443–8.
Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol. 2000;174(3):623–7.
Augustin H, Graefen M, Palisaar J, et al. Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging. J Clin Oncol. 2003;21(15):2860–8.
Burns PN, Wilson SR. Microbubble contrast for radiological imaging: 1. Principles. Ultrasound Q. 2006;22(1):5–13.
de Jong N. Mechanical index. Eur J Echocardiogr. 2002;3(1):73–4.
Linden RA, Trabulsi EJ, Forsberg F, Gittens PR, Gomella LG, Halpern EJ. Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. J Urol. 2007;178(6):2354–8.
Futterer JJ, Barentsz J, Heijmijnk ST. Imaging modalities for prostate cancer. Expert Rev Anticancer Ther. 2009;9(7):923–37.
Aigner F, Pallwein L, Mitterberger M, et al. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int. 2009;103(4):458–63.
Mitterberger M, Pinggera GM, Horninger W, et al. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol. 2007;178(2):464–8; discussion 468.
Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol. 2002;167(4):1648–52.
Pelzer A, Bektic J, Berger AP, et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol. 2005;173(6):1926–9.
Halpern EJ, Ramey JR, Strup SE, Frauscher F, McCue P, Gomella LG. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer. 2005;104(11):2373–83.
Mitterberger M, Horninger W, Pelzer A, et al. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection. Prostate. 2007;67(14):1537–42.
Mitterberger MJ, Aigner F, Horninger W, et al. Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection. Eur Radiol. 2010;20(12):2791–6.
Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging. 1991;13(2):111–34.
Pallwein L, Mitterberger M, Struve P, et al. Real-time elastography for detecting prostate cancer: preliminary experience. BJU Int. 2007;100(1):42–6.
Salomon G, Kollerman J, Thederan I, et al. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol. 2008;54(6):1354–62.
Pallwein L, Mitterberger M, Pinggera G, et al. Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients. Eur J Radiol. 2008;65(2):304–10.
Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology. 2007;70(6):1136–40.
Eggert T, Khaled W, Wenske S, Ermert H, Noldus J. Impact of elastography in clinical diagnosis of prostate cancer. A comparison of cancer detection between B-mode sonography and elastography-guided 10-core biopsies. Stellenwert der Elastographie in der klinischen Diagnostik des lokalisierten Prostatakarzinoms. Vergleich von Detektionsraten der B-Modus-Sonographie und der elastographieunterstutzten systematischen 10fach-Biopsie. Urologe A. 2008;47(9):1212–7.
Braeckman J, Autier P, Garbar C, et al. Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int. 2008;101(3):293–8.
Braeckman J, Autier P, Soviany C, et al. The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int. 2008;102(11):1560–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
van den Heuvel, S., Verhagen, P.C.M.S., Bangma, C.H. (2013). The Role of Ultrasonography. In: Tewari, A. (eds) Prostate Cancer: A Comprehensive Perspective. Springer, London. https://doi.org/10.1007/978-1-4471-2864-9_39
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2864-9_39
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2863-2
Online ISBN: 978-1-4471-2864-9
eBook Packages: MedicineMedicine (R0)